Plant Comparison
Purple coneflower vs Holy Basil
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Purple coneflower and Holy Basil: they share 5 indicated uses (arthritis / joint pain, cold & flu, immune support, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Purple coneflower | Holy Basil | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Cold & flu | 1/10 | 7/10 | Stronger for Holy Basil |
| Immune support | 1/10 | 7/10 | Stronger for Holy Basil |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Lipophilic alkamides are considered key immunomodulatory and anti-inflammatory constituents, particularly concentrated in the root.
Antioxidant phenolic compounds contributing to the plant's immunomodulatory activity.
Water-soluble polysaccharides associated with immune-stimulating activity, particularly from the aerial parts.
Pharmacological Actions
Adaptogen for stress and anxiety (improves stress scores and well-being in trials)
Cognitive support - a placebo-controlled study in healthy adults found improved reaction time and accuracy and shorter P300 latency
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from immunomodulator action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Adaptogen for stress and anxiety (improves stress scores and well-being in trials)
inferred from anti-inflammatory action
Supports blood-sugar control (lowers fasting and post-meal glucose)
inferred from anticancer action
inferred from neuroprotective action
inferred from adaptogen action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally considered safe, but caution advised for those with autoimmune conditions. Not recommended for long-term use (more than 8 weeks continuously).
Duke (2002) rates echinacea as +++ — among the most thoroughly documented herbal immunostimulants. It notes experimental and clinical evidence for immunostimulant, antiviral, and anti-inflammatory activities. Multiple species have been studied (E. purpurea, E. angustifolia, E. pallida), and Duke emphasizes that species identification in commercial products is often unreliable. Commission E approves E. purpurea for supporting immune function during colds and flu. Dose: 900 mg standardized extract daily in acute use; use should be limited to 8 weeks continuous. Contraindicated in autoimmune diseases (MS, lupus, HIV/AIDS), tuberculosis, and with immunosuppressive drugs (cyclosporine) (Duke, 2002).
Generally well tolerated; mild nausea has been reported. Its blood-sugar-lowering effect means caution alongside antidiabetic medicines.
External Ids
Botanical Description
Robust perennial herb with a basal rosette of coarse, hairy, lance-shaped leaves and tall, sturdy flowering stems. Each stem bears a single large, daisy-like flower head with drooping (reflexed), rose-purple to pink ray florets surrounding a prominent, spiny, orange-brown central cone of disc florets.[4]
Aromatic annual or short-lived perennial subshrub (Lamiaceae), 30-75 cm tall, with erect, much-branched, hairy stems often tinged purple. Leaves are opposite, ovate-oblong with a toothed margin, and release a strong, clove-like (eugenol) scent when crushed. Small purplish-pink, two-lipped flowers are borne in elongated terminal racemes. The plant is held sacred in Hindu tradition (Tulsi).[11]
Habitat
Native to the tallgrass prairies, open woodland and dry meadows of central and eastern North America; widely cultivated worldwide as a garden and medicinal plant.[4]
Native to the Indian subcontinent and tropical Asia, now cultivated and naturalised throughout the tropics and subtropics worldwide; commonly grown in home gardens and temple courtyards as well as cultivated as a medicinal and aromatic crop.[12]
Harvesting
The flower heads are picked as they open, in summer; the root is dug in autumn from plants at least two to three years old, when its content of bioactive alkamides and caffeic acid derivatives is highest, then cleaned and dried.[4]
Leaves are harvested year-round from actively growing plants, ideally picked once morning dew has dried; whole flowering tops are also gathered.
Traditional Uses
Echinacea root was widely used by Native American peoples as a remedy for infections, wounds, snakebite and toothache, and entered nineteenth-century Eclectic medicine as a broad anti-infective. It remains best known today, in standardised aerial-part or root extracts, as a supportive remedy for preventing and shortening the common cold and supporting immune function.[1, 4]
Tulsi is one of the most revered plants in Ayurvedic medicine, traditionally used as an adaptogen for stress, a remedy for respiratory complaints (colds, cough, asthma), and a general immune tonic. Modern clinical trials support adaptogenic/anti-stress, blood-sugar-lowering and immunomodulatory effects consistent with these traditional uses.[3, 12]
Preparations
Fresh-pressed juice or standardised extract of the aerial parts or root, taken as tablets, drops or capsules at the first sign of a cold; the best-studied clinical form.
Dosage
Clinical trials for the common cold commonly use around 300-900 mg of standardised extract daily, started at the first sign of symptoms and continued for up to 7-10 days; continuous use beyond about 8 weeks is not recommended. Educational reference only, not a prescription.
Clinical trials for stress and mood have used standardised dry-extract capsules taken over several weeks; dosing varies by product concentration, so follow the manufacturer's guidance. Educational reference only, not a prescription.
The WHO monograph on Folium Ocimi Sancti gives a daily dosage of 6-12 g of the crude drug as a decoction. This is a whole-day total for the fresh or dried leaf, notably higher than the 1-2 g per cup often quoted in popular sources. Educational reference only, not a prescription.
References
Drug Class Interactions
Lookalikes Review
References & Sources
- Karsch-Völk, M., Barrett, B., Kiefer, D., Bauer, R. et al (2014) 'Echinacea for preventing and treating the common cold', Cochrane Database of Systematic Reviews, 2(2), pp. CD000530. doi:10.1002/14651858.CD000530.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD000530.pub3 - Kamin, W., Seifert, G., Zwiauer, K., Bonhoeffer, J. et al (2025) 'Phytotherapy for acute respiratory tract infections in children: a systematically conducted, comprehensive review', Frontiers in Pediatrics, 13, pp. 1423250. doi:10.3389/fped.2025.1423250 Meta-analysis / review
https://doi.org/10.3389/fped.2025.1423250 - Fashner, J., Ericson, K. and Werner, S (2012) 'Treatment of the common cold in children and adults', American Family Physician, 86(2), pp. 153-159. Available at: https://pubmed.ncbi.nlm.nih.gov/22962927/ Traditional / reference
https://pubmed.ncbi.nlm.nih.gov/22962927/ - Manayi, A., Vazirian, M. and Saeidnia, S (2015) 'Echinacea purpurea: Pharmacology, phytochemistry and analysis methods', Pharmacognosy Reviews, 9(17), pp. 63-72. doi:10.4103/0973-7847.156353 Meta-analysis / review
https://doi.org/10.4103/0973-7847.156353 - Burlou-Nagy, C., Banica, F., Jurca, T., Vicas, L.G., Marian, E., Muresan, M.E., Bacskay, I., Kiss, R., Feher, P. and Pallag, A (2022) 'Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review', Plants, 11(9), pp. 1244. doi:10.3390/plants11091244 Meta-analysis / review
https://doi.org/10.3390/plants11091244 - Hall, H., Fahlman, M.M. and Engels, H.J (2007) 'Echinacea purpurea and mucosal immunity', International Journal of Sports Medicine, 28(9), pp. 792-797. doi:10.1055/s-2007-964895 Randomized trial
https://doi.org/10.1055/s-2007-964895 - Ross, S.M (2016) 'Echinacea purpurea: A Proprietary Extract of Echinacea purpurea Is Shown to be Safe and Effective in the Prevention of the Common Cold', Holistic Nursing Practice, 30(1), pp. 54-57. doi:10.1097/HNP.0000000000000130 Meta-analysis / review
https://doi.org/10.1097/HNP.0000000000000130 - Hudson, J.B (2011) 'Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases', Journal of Biomedicine & Biotechnology, 2012, pp. 769896. doi:10.1155/2012/769896 Meta-analysis / review
https://doi.org/10.1155/2012/769896 - Mishima, S., Saito, K., Maruyama, H., Inoue, M., Yamashita, T., Ishida, T. and Gu, Y (2004) 'Antioxidant and immuno-enhancing effects of Echinacea purpurea', Biological & Pharmaceutical Bulletin, 27(7), pp. 1004-1009. doi:10.1248/bpb.27.1004 Preclinical
https://doi.org/10.1248/bpb.27.1004 - Saunders, P.R., Smith, F. and Schusky, R.W (2007) 'Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections', Canadian Journal of Physiology and Pharmacology, 85(11), pp. 1195-1199. doi:10.1139/Y07-103 Clinical study
https://doi.org/10.1139/Y07-103 - Micheli, L., Maggini, V., Ciampi, C., Gallo, E., Bogani, P., Fani, R., Pistelli, L., Ghelardini, C., Di Cesare Mannelli, L., De Leo, M. and Firenzuoli, F (2022) 'Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy', Phytotherapy Research, 37(5), pp. 1911-1923. doi:10.1002/ptr.7709 Preclinical
https://doi.org/10.1002/ptr.7709 - Gholami, M., Amri, J., Pazhoohan, S. and Sadegh, M (2021) 'Anticonvulsive and anti-epileptogenesis effects of Echinacea purpurea root extract, an involvement of CB2 receptor', Journal of Complementary & Integrative Medicine, 19(4), pp. 879-886. doi:10.1515/jcim-2020-0219 Preclinical
https://doi.org/10.1515/jcim-2020-0219 - Awortwe, C., Bruckmueller, H., Kaehler, M. and Cascorbi, I (2021) 'Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux Transporters', Molecular Pharmaceutics, 18(4), pp. 1622-1633. doi:10.1021/acs.molpharmaceut.0c01075 Preclinical
https://doi.org/10.1021/acs.molpharmaceut.0c01075 - Perry, N.B., van Klink, J.W., Burgess, E.J. and Parmenter, G.A (1997) 'Alkamide levels in Echinacea purpurea: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers', Planta Medica, 63(1), pp. 58-62. doi:10.1055/s-2006-957605 Preclinical
https://doi.org/10.1055/s-2006-957605 - Linde, K., Barrett, B., Wölkart, K., Bauer, R. and Melchart, D (2006) 'Echinacea for preventing and treating the common cold'. Traditional / reference
https://scholar.google.com/scholar?q=Echinacea%20for%20preventing%20and%20treating%20the%20common%20cold - Sharma, M., Schoop, R., Suter, A. and Schoop, W (2010) 'The possibility of prophylactic treatment of streptococcal pharyngotonsillitis with a standardized Echinacea preparation', 29(8), pp. 1025--1035. Traditional / reference
https://scholar.google.com/scholar?q=The%20possibility%20of%20prophylactic%20treatment%20of%20streptococcal%20pharyngotonsillitis%20with%20a%20standardized%20Echinacea%20preparation - World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Gorski, J.C., Huang, S.M., Pinto, A., Hamman, M.A., Hilligoss, J.K., Zaheer, N.A., Desai, M., Miller, M. and Hall, S.D (2004) 'The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo', Clinical Pharmacology and Therapeutics, 75(1), pp. 89-100. doi:10.1016/j.clpt.2003.09.013 Clinical study
https://doi.org/10.1016/j.clpt.2003.09.013
- Lopresti, A.L., Smith, S.J., Metse, A.P. and Drummond, P.D (2022) 'A randomized, double-blind, placebo-controlled trial investigating the effects of an Ocimum tenuiflorum (Holy Basil) extract (Holixer) on stress, mood, and sleep in adults experiencing stress', Frontiers in Nutrition, 9, pp. 965130. doi:10.3389/fnut.2022.965130 Randomized trial
https://doi.org/10.3389/fnut.2022.965130 - Baliga, M.S., Jimmy, R., Thilakchand, K.R., Sunitha, V. and others (2013) 'Ocimum sanctum L (Holy Basil or Tulsi) and its phytochemicals in the prevention and treatment of cancer', Nutrition and Cancer, 65(Suppl 1), pp. 26-35. doi:10.1080/01635581.2013.785010 Meta-analysis / review
https://doi.org/10.1080/01635581.2013.785010 - Cohen, M.M (2014) 'Tulsi - Ocimum sanctum: A herb for all reasons', Journal of Ayurveda and Integrative Medicine, 5(4), pp. 251-259. doi:10.4103/0975-9476.146554 Meta-analysis / review
https://doi.org/10.4103/0975-9476.146554 - Arya, R., Faruquee, H.M., Shakya, H., Rahman, S.A. and others (2024) 'Harnessing the Antibacterial, Anti-Diabetic and Anti-Carcinogenic Properties of Ocimum tenuiflorum Linn (Tulsi)', Plants, 13(24), pp. 3516. doi:10.3390/plants13243516 Preclinical
https://doi.org/10.3390/plants13243516 - Prakash, P. and Gupta, N (2005) 'Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review', Indian Journal of Physiology and Pharmacology, 49(2), pp. 125-131. Meta-analysis / review
https://scholar.google.com/scholar?q=Therapeutic%20uses%20of%20Ocimum%20sanctum%20Linn%20%28Tulsi%29%20with%20a%20note%20on%20eugenol%20and%20its%20pharmacological%20actions%3A%20a%20short%20review - Jayapal, V., Vidya Raj, C.K., Muthaiah, M., Chadha, V.K. and others (2021) 'In-vitro anti-Mycobacterium tuberculosis effect of essential oil of Ocimum sanctum L. (Tulsi/Basil) leaves', Indian Journal of Tuberculosis, 68(4), pp. 470-473. doi:10.1016/j.ijtb.2021.02.009 Preclinical
https://doi.org/10.1016/j.ijtb.2021.02.009 - Baliga, M.S., Rao, S., Rai, M.P. and D'souza, P (2016) 'Radio protective effects of the Ayurvedic medicinal plant Ocimum sanctum Linn. (Holy Basil): A memoir', Journal of Cancer Research and Therapeutics, 12(1), pp. 20-27. doi:10.4103/0973-1482.151422 Meta-analysis / review
https://doi.org/10.4103/0973-1482.151422 - Kamel, F.O., Karim, S., Bafail, D.A.O., Aldawsari, H.M. and others (2023) 'Hepatoprotective effects of bioactive compounds from traditional herb Tulsi (Ocimum sanctum Linn) against galactosamine-induced hepatotoxicity in rats', Frontiers in Pharmacology, 14, pp. 1213052. doi:10.3389/fphar.2023.1213052 Preclinical
https://doi.org/10.3389/fphar.2023.1213052 - Yadav, I., Kumar, R., Fatima, Z. and Rema, V (2024) 'Ocimum sanctum (Tulsi) as a Potential Immunomodulator for the Treatment of Ischemic Injury in the Brain', Current Molecular Medicine, 24(1), pp. 60-73. doi:10.2174/1566524023666221212155340 Meta-analysis / review
https://doi.org/10.2174/1566524023666221212155340 - Kumar, P. and Patel, D (2023) 'Ocimum Sanctum: An All-Round Treatment for Cancer?', Alternative Therapies in Health and Medicine, 29(4), pp. 253-257. Meta-analysis / review
https://scholar.google.com/scholar?q=Ocimum%20Sanctum%3A%20An%20All-Round%20Treatment%20for%20Cancer%3F - Bhattacharyya, P. and Bishayee, A (2013) 'Ocimum sanctum Linn. (Tulsi): an ethnomedicinal plant for the prevention and treatment of cancer', Anti-Cancer Drugs. doi:10.1097/CAD.0b013e328361aca1 Traditional / reference
https://doi.org/10.1097/CAD.0b013e328361aca1 - Jamshidi, N. and Cohen, M.M (2017) 'The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature', Evidence-Based Complementary and Alternative Medicine. doi:10.1155/2017/9217567 Meta-analysis / review
https://doi.org/10.1155/2017/9217567 - World Health Organization (2002) 'Folium Ocimi Sancti'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Sampath, S., Mahapatra, S.C., Padhi, M.M., Sharma, R. and Talwar, A (2015) 'Holy basil (Ocimum sanctum Linn.) leaf extract enhances specific cognitive parameters in healthy adult volunteers: A placebo controlled study', Indian Journal of Physiology and Pharmacology, 59(1), pp. 69--77. Randomized trial
https://scholar.google.com/scholar?q=Holy%20basil%20%28Ocimum%20sanctum%20Linn.%29%20leaf%20extract%20enhances%20specific%20cognitive%20parameters%20in%20healthy%20adult%20volunteers%3A%20A%20placebo%20controlled%20study - Jamshidi, N. and Cohen, M.M (2017) 'The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature', Evidence-Based Complementary and Alternative Medicine, 2017, pp. 9217567. doi:10.1155/2017/9217567 Meta-analysis / review
https://doi.org/10.1155/2017/9217567 - Agrawal, P., Rai, V. and Singh, R.B (1996) 'Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus', International Journal of Clinical Pharmacology and Therapeutics, 34(9), pp. 406-409. Randomized trial
https://scholar.google.com/scholar?q=Randomized%20placebo-controlled%2C%20single%20blind%20trial%20of%20holy%20basil%20leaves%20in%20patients%20with%20noninsulin-dependent%20diabetes%20mellitus
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.